F/M Investments’s Pfizer PFE Stock Holding History

F/M Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.15M	Sell	47,630 -28,540	-37%	-$747K	0.06%	172
2026 Q1	$2.14M	Sell	76,170 -220,786	-74%	-$5.88M	0.14%	103
2025 Q4	$7.39M	Buy	296,956 +184,420	+164%	+$4.65M	0.28%	90
2025 Q3	$2.87M	Sell	112,536 -3,953	-3%	-$97.6K	0.11%	194
2025 Q2	$2.82M	Buy	116,489 +6,472	+6%	+$151K	0.1%	196
2025 Q1	$2.79M	Buy	110,017 +15,966	+17%	+$418K	0.11%	187
2024 Q4	$2.5M	Buy	94,051 +12,895	+16%	+$350K	0.09%	200
2024 Q3	$2.34M	Sell	81,156 -6,743	-8%	-$197K	0.07%	205
2024 Q2	$2.46M	Buy	+87,899	New	+$2.42M	0.09%	197
2022 Q2	–	Sell	-62,684	Closed	-$3.25M	–	86
2022 Q1	$3.25M	Sell	62,684 -107	-0.2%	-$5.55K	2.62%	10
2021 Q4	$3.71M	Buy	62,791 +58,051	+1,225%	+$2.88M	2.71%	10
2021 Q3	$204K	Buy	+4,740	New	+$210K	0.15%	77

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

F/M Investments's PFE Position: Q2 2026 in Review

F/M Investments reduced its Pfizer (PFE) stake by 37% in Q2 2026, selling an estimated $747K and leaving 47,630 shares worth $1.15M. The position accounts for 0.06% of the portfolio, ranked #172.

F/M Investments first reported a position in PFE in Q3 2021 and has held it in 12 quarters since. The position peaked at $7.39M in Q4 2025. 2,828 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

F/M Investments held 47,630 shares of Pfizer worth $1.15M as of Q2 2026.
F/M Investments sold 28,540 Pfizer shares in Q2 2026, an estimated $747K.
Pfizer made up 0.06% of F/M Investments's portfolio in Q2 2026, its #172 holding.
F/M Investments first reported a position in Pfizer in Q3 2021 and has held it in 12 quarters since.
F/M Investments's Pfizer position peaked at $7.39M in Q4 2025.
2,828 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.